Skip to content
HowShorted

Sorrento Therapeutics, Inc. short interest in 2019

In 2019, Sorrento Therapeutics, Inc.'s disclosed short interest ran from 17.10% of shares outstanding on 15 Jan 2019 to 17.00% on 31 Dec 2019, a change of -0.10 percentage points. The year's high was 17.10% on 15 Jan 2019 and its low 7.89% on 31 Jul 2019, averaging 12.58% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.70 days on 30 Aug 2019. Full history: Sorrento Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for Sorrento Therapeutics, Inc. in 2019

2019 in figures

Start of year
17.10% (15 Jan 2019)
End of year
17.00% (31 Dec 2019)
Change
-0.10 pp
High
17.10% (15 Jan 2019)
Low
7.89% (31 Jul 2019)
Average
12.58%
Highest days to cover
20.70 (30 Aug 2019)
SEC filings marked
7

Every report in 2019

Sorrento Therapeutics, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201917.10%15.23
31 Jan 201916.41%14.17
15 Feb 201915.60%15.33results (8-K)
28 Feb 201915.40%14.90
15 Mar 201916.29%7.7010-K filed
29 Mar 201912.27%1.69
15 Apr 201912.99%6.55
30 Apr 201912.78%16.06
15 May 201912.67%15.89results (8-K), 10-Q filed
31 May 201912.50%16.97
14 Jun 201912.55%20.57results (8-K)
28 Jun 201912.65%7.12
15 Jul 20199.97%8.85
31 Jul 20197.89%12.91
15 Aug 20199.09%17.2510-Q filed
30 Aug 20198.72%20.70
13 Sep 20198.76%12.94
30 Sep 20199.64%13.80
15 Oct 201910.22%4.00
31 Oct 20199.66%14.32
15 Nov 201910.36%11.5010-Q filed
29 Nov 201915.73%1.69
13 Dec 201915.62%2.01
31 Dec 201917.00%6.85

See also: Sorrento Therapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.